These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9257885

  • 1. Effect of sublethal total body irradiation on acute graft-versus-host disease and graft-versus-leukemia effect in SCID mice.
    Sakai R, Maruta A, Yanoma S, Shimizu A, Harada M, Nakamura Y, Kodama F, Okubo T.
    Bone Marrow Transplant; 1997 Aug; 20(3):183-9. PubMed ID: 9257885
    [Abstract] [Full Text] [Related]

  • 2. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
    Xun CQ, Thompson JS, Jennings CD, Brown SA.
    Transplantation; 1995 Oct 27; 60(8):821-7. PubMed ID: 7482742
    [Abstract] [Full Text] [Related]

  • 3. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G, Truitt RL, Johnson BD.
    Biol Blood Marrow Transplant; 2006 Apr 27; 12(4):397-407. PubMed ID: 16545723
    [Abstract] [Full Text] [Related]

  • 4. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD, Becker EE, Truitt RL.
    Biol Blood Marrow Transplant; 1999 Apr 27; 5(3):123-32. PubMed ID: 10392958
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Apr 27; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 7. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y, Guo K, Chen Y, Song Z, Li J, Deng L.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug 27; 23(8):411-4. PubMed ID: 12411044
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B, Li DP, Xu KL, Pan XY.
    Chin Med J (Engl); 2005 Mar 20; 118(6):474-9. PubMed ID: 15788128
    [Abstract] [Full Text] [Related]

  • 10. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.
    Hsieh MH, Varadi G, Flomenberg N, Korngold R.
    Biol Blood Marrow Transplant; 2002 Mar 20; 8(6):303-15. PubMed ID: 12108916
    [Abstract] [Full Text] [Related]

  • 11. A novel approach for prevention of lethal GVHD by selective elimination of alloreactive donor lymphocytes prior to stem cell transplantation.
    Panigrahi S, Morecki S, Yacovlev E, Gelfand Y, Kassir J, Slavin S.
    Exp Hematol; 2004 Aug 20; 32(8):756-64. PubMed ID: 15308327
    [Abstract] [Full Text] [Related]

  • 12. Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.
    Yang I, Weiss L, Abdul-Hai A, Kasir J, Reich S, Slavin S.
    Cancer Res; 2005 Nov 01; 65(21):9735-40. PubMed ID: 16266994
    [Abstract] [Full Text] [Related]

  • 13. CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.
    Blazar BR, Taylor PA, Boyer MW, Panoskaltsis-Mortari A, Allison JP, Vallera DA.
    J Immunol; 1997 Oct 01; 159(7):3460-73. PubMed ID: 9317145
    [Abstract] [Full Text] [Related]

  • 14. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2003 Apr 01; 9(4):243-56. PubMed ID: 12720217
    [Abstract] [Full Text] [Related]

  • 15. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y, Margalit M, Ohana M, Gotsman I, Rabbani E, Engelhardt D, Nagler A.
    Hum Immunol; 2005 Mar 01; 66(3):231-40. PubMed ID: 15784461
    [Abstract] [Full Text] [Related]

  • 16. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti FW, Murphy WJ.
    J Clin Invest; 1998 May 01; 101(9):1835-42. PubMed ID: 9576746
    [Abstract] [Full Text] [Related]

  • 17. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M.
    Biol Blood Marrow Transplant; 1999 May 01; 5(3):133-43. PubMed ID: 10392959
    [Abstract] [Full Text] [Related]

  • 18. [Study on graft-versus-leukemia effects of donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation].
    Du B, Li D, Xu K.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug 01; 22(8):403-7. PubMed ID: 11718089
    [Abstract] [Full Text] [Related]

  • 19. Effect of KRN7000 on induced graft-vs-host disease.
    Morecki S, Panigrahi S, Pizov G, Yacovlev E, Gelfand Y, Eizik O, Slavin S.
    Exp Hematol; 2004 Jul 01; 32(7):630-7. PubMed ID: 15246159
    [Abstract] [Full Text] [Related]

  • 20. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB, Elkin G, Khitrin S, Slavin S.
    Exp Hematol; 2008 Dec 01; 36(12):1750-9. PubMed ID: 18809241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.